Suppression of type II bone morphogenic protein receptor in vascular smooth muscle induces pulmonary arterial hypertension in transgenic mice.

Chest ·Vol. 128 ·No. 6 Suppl ·2005-12-00 ·Pages 553S

West J, Tada Y, Fagan KA, Steudel W, Fouty BW, Harral JW, Miller M, Ozimek J, Tuder RM, Rodman DM

Abstract

暂无摘要

MeSH Terms

Animals Bone Morphogenetic Protein Receptors, Type II/genetics,physiology Hypertension, Pulmonary/genetics Mice Mice, Transgenic Muscle, Smooth, Vascular/chemistry

Chemicals

Bone Morphogenetic Protein Receptors, Type II

Authors & Affiliations

10 authors, click to expand affiliations / ORCID

West James

Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, CO, USA. [email protected]

Tada Yuji

Fagan Karen A

Steudel Wolfgang

Fouty Brian W

Harral Julie Wright

Miller Marloes

Ozimek John

Tuder Rubin M

Rodman David M

Article Info

Journal

Chest

Abbr.

Chest

ISSN

0012-3692

DOI

10.1378/chest.128.6_suppl.553S

[email protected]

Published

2005-12-00

Pages

553S

Language

English

Region

United States

NLM ID

0231335

Subset

External Links

PubMed source DOI: 10.1378/chest.128.6_suppl.553S View journal details

Analysis Services

Suppression of type II bone morphogenic protein receptor in vascular smooth muscle induces pulmonary arterial hypertension in transgenic mice.

Contact

WeChat Official Account